Home / Treatments / Real Time Heart Monitor

Real Time Heart Monitor denials: what the review data shows

Independent reviewers have decided 12 published cases where an insurer denied Real Time Heart Monitor — and they overturned the insurer 33.3% of the time. A denial for Real Time Heart Monitor is a starting position, not a final answer.

Published decisions
12
2001–2026
Overturned
33.3%
4 denials reversed

Conditions behind real time heart monitor denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Atrial Fibrillation5
40%
Syncope4
50%
Typical time to a decision
16 days
Most land between 12 and 21 days
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: The patient’s parent has requested reimbursement for a real time heart monitor for evaluation of the enrollee’s heart murmur. In young patients it is difficult to differentiate cardiac versus non-cardiac causes of syncope. Patients may present with seizure-like activity even though the primary issue is not neurologic. In this patient’s case, his seizure-like activity is being considered as potentially of cardiac origin. An evaluation is currently underway, including a period of ambulatory cardiac monitoring. Ambulatory electrocardiography monitors, or real time heart monitors, are devices designed for use at home to record the electrical activity of the heart while the patient is performing normal daytime activities.
Experimental/Investigational · 2017 · IMR EI17-27272
A 46-year-old female enrollee has requested for use of a real-time heart monitor evaluation of her hypertrophic cardiomyopathy. Findings: Two physician reviewers found that the use of a real-time heart monitor was likely to have been of greater efficacy than other modalities for evaluating this patient. Reiffel and colleagues examined whether the newer auto-triggered (real-time) ambulatory monitors have higher yield for the detection of both symptomatic and asymptomatic arrhythmias when compared to traditional Holter monitors and traditional event monitors. The authors concluded that auto-triggered/real-time devices are superior to standard event monitor devices for the detection of asymptomatic arrhythmias, including atrial fibrillation.
Experimental/Investigational · 2012 · IMR EI12-13778

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
A 64-year-old male enrollee has requested a Real-Time Heart Monitor for the treament of his paroxysmal supraventricular tachycardia and syncope. Findings: Two physician reviewers found that based on the records provided, the patient underwent two weeks of continuous outpatient mobile cardiac telemetry to assess for a cause of syncope under the diagnosis code of paroxysmal supraventricular tachycardia. In this circumstance, if cardiac monitoring were thought to be medically necessary then non-real time (off-line) monitoring devices such as Holter monitoring or event monitoring should be sufficient for identification of both symptomatic and asymptomatic dysrhythmias. Continuous off-line 24-48 hour Holter monitoring should be able to effectively identify symptomatic or asymptomatic dysrhythmias that occur frequently.
Experimental/Investigational · 2011 · IMR EI11-12146
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for services, specifically the use of a real time heart monitor for evaluation of the enrollee who presented with premature ventricular contractions. Findings: The physician reviewers found that the documentation provided does not support the superior efficacy of the services at issue in this clinical setting. The records provided indicate that this patient had intermittent palpitations. In this circumstance, if additional evaluation for a dysrhythmia is thought to be necessary then prolonged serial 48 hour Holter monitoring or off line self activated or auto triggered cardiac event monitoring should be sufficient in recording cardiac rhythm during symptoms.
Experimental/Investigational · 2017 · IMR EI17-26392

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Real Time Heart Monitorwhen you appeal: reviewers routinely find that denials like yours didn’t hold up.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Real Time Heart Monitor? 33.3% got it reversed.

Explain my denial — freeStart my appeal · $39